Professional Practice Resources

Adverse Reaction Reporting

• Health Canada MedEffect Program

• Adverse Reaction Reporting Information

• Guidelines for Reporting Suspected Adverse Reactions to Antiviral Drugs During an Influenza Pandemic

• Report an Adverse Reaction to a Drug or Other Health Product

• Canadian Adverse Reaction Newsletters Year-To-Date

  • January 2010

  • April 2010

  • July 2010

• Canadian Adverse Reaction Newsletters Archives

  • Index-To-Date

• Search the CADRMP Online Database

Narcotics and Controlled Drugs

• General

  • Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain  

• Methadone

• Standards of Pharmacy Practice for Pharmacists for the Newfoundland and Labrador Methadone Maintenance Program

• Methadone Maintenance: A Pharmacist's Guide to Treatment. Brands and Janecek. Available in hard copy only from the Centre for Addiction and Mental Health (www.camh.net)

• Health Canada Methadone Program  

• College of Physicians and Surgeons of Newfoundland and Labrador Methadone Maintenance Treatment Guidelines

• Crystal Meth

  • MethWatch Program

• Medical Marijuana

  • Health Canada Medical Use of Marijuana

H1N1 Influenza

• NL Government Department of Health and Community Services

  • Information on H1N1 Influenza Virus (Human Swine Influenza)

  • "How to Wash Hands" poster

  • "How to Sanitize Hands" poster

• Public Health Agency of Canada

  • FightFlu.ca

  • "Protect Yourself" Poster

• Other Groups

  • Pandemic Practice Resources for Pharmacists - Canadian Pharmacists Association

  • H1N1 Influenza Preparedness Information Kits - Ontario's Community Pharmacies

• Extemporaneous Preparation of TAMIFLU Suspension 

  • Mixing TAMIFLU Capsules by Care-givers(Roche)

  • Emergency Preparation of TAMIFLU Oral Suspension(Roche)(using Ora-Sweet-SF)

• Methylcellulose 1% (Sick Kids)

• oseltamivir 12mg/mL Oral Suspension (IWK) (using methylcellulose 1%)

• Tamiflu Formulas (Medisca Networks Inc.)